DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,827,997 | -11.0% | 7,368 | -13.9% | 0.03% | -8.6% |
Q2 2023 | $2,052,860 | +117880.5% | 8,554 | +23.9% | 0.04% | -2.8% |
Q1 2023 | $1,740 | +2.1% | 6,904 | +7.5% | 0.04% | -21.7% |
Q4 2022 | $1,705 | -99.9% | 6,423 | +3.3% | 0.05% | -9.8% |
Q3 2022 | $1,606,000 | +0.4% | 6,217 | -1.4% | 0.05% | +2.0% |
Q2 2022 | $1,599,000 | -16.4% | 6,307 | -3.3% | 0.05% | -13.8% |
Q1 2022 | $1,913,000 | -3.8% | 6,523 | +7.9% | 0.06% | -1.7% |
Q4 2021 | $1,988,000 | +29.8% | 6,043 | +20.1% | 0.06% | +18.0% |
Q3 2021 | $1,531,000 | +29.2% | 5,030 | +13.9% | 0.05% | +19.0% |
Q2 2021 | $1,185,000 | +44.0% | 4,415 | +20.8% | 0.04% | +23.5% |
Q1 2021 | $823,000 | +36.3% | 3,655 | +34.5% | 0.03% | +17.2% |
Q4 2020 | $604,000 | +1.7% | 2,718 | -1.6% | 0.03% | -21.6% |
Q3 2020 | $594,000 | +21.2% | 2,761 | -0.4% | 0.04% | +5.7% |
Q2 2020 | $490,000 | +22.8% | 2,773 | -3.8% | 0.04% | -5.4% |
Q1 2020 | $399,000 | +24.7% | 2,882 | +38.1% | 0.04% | +37.0% |
Q4 2019 | $320,000 | +13.1% | 2,087 | +6.7% | 0.03% | -15.6% |
Q3 2019 | $283,000 | – | 1,956 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |